Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

We calculated the number and growth rate of Plasmodium falciparum parasites emerging in recipients of candidate preerythrocytic malaria vaccines and unvaccinated control subjects undergoing mosquito-bite challenge. This was done to measure vaccine efficacy and to distinguish the effects on blood-stage multiplication from those on liver-stage parasites. Real-time polymerase chain reaction measurements of parasite densities were analyzed by nonlinear regression and mixed-effects models. Substantial reductions in numbers of liver parasites resulted from the use of 2 immunization regimens: FP9 boosted by modified virus Ankara (MVA) encoding the malaria epitope-thrombospondin-related adhesion protein insert (92% reduction) and RTS,S/AS02 used in heterologous prime-boost immunization regimens, with MVA encoding the circumsporozoite protein (97% reduction). Forty-eight-hour growth rates in blood from control subjects were not different from those in blood from any vaccination group (mean, 14.4-fold [95% confidence interval, 11-19-fold]).

Original publication

DOI

10.1086/427243

Type

Journal article

Journal

J Infect Dis

Publication Date

15/02/2005

Volume

191

Pages

619 - 626

Keywords

Animals, Antigens, Protozoan, Bayes Theorem, Blood, DNA, Protozoan, Humans, Liver, Malaria, Malaria Vaccines, Markov Chains, Models, Biological, Models, Statistical, Nonlinear Dynamics, Plasmodium falciparum, Polymerase Chain Reaction, Regression Analysis, Sporozoites, Vaccination, Vaccines, Synthetic